What is a clinical practice guideline? A roadmap to their development. Special report from the Guidelines Task Force of the International League Against Epilepsy.
ADAPTE process
GRADE
best practices
dissemination
guideline development
implementation
Journal
Epilepsia
ISSN: 1528-1167
Titre abrégé: Epilepsia
Pays: United States
ID NLM: 2983306R
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
revised:
21
05
2022
received:
18
01
2022
accepted:
23
05
2022
pubmed:
21
6
2022
medline:
12
8
2022
entrez:
20
6
2022
Statut:
ppublish
Résumé
Clinical practice guidelines (CPGs) are statements that provide evidence-based recommendations aimed at optimizing patient care. However, many other documents are often published as "guidelines" when they are not; these documents, although also important in clinical practice, are usually not systematically produced following rigorous processes linking the evidence to the recommendations. Specifically, the International League Against Epilepsy (ILAE) guideline development toolkit aims to ensure that high-quality CPGs are developed to fill knowledge gaps and optimize the management of epilepsy. In addition to adhering to key methodological processes, guideline developers need to consider that effective CPGs should lead to improvements in clinical processes of care and health care outcomes. This requires monitoring the effectiveness of epilepsy-related CPGs and interventions to remove the barriers to epilepsy CPG implementation. This article provides an overview of what distinguishes quality CPGs from other documents and discusses their benefits and limitations. We summarize the recently revised ILAE CPG development process and elaborate on the barriers and facilitators to guideline dissemination, implementation, and adaptation.
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1920-1929Subventions
Organisme : NINDS NIH HHS
ID : U24 NS107201
Pays : United States
Organisme : NINDS NIH HHS
ID : U54 NS100064
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS097719
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002548
Pays : United States
Informations de copyright
© 2022 International League Against Epilepsy.
Références
Greenfield S, Steinberg EP, Auerbach A, Avorn J, Galvin RS, Gibbons R, et al. Clinical practice guidelines we can trust. Washington, DC: National Academies Press; 2011.
Shekelle PG. Clinical practice guidelines: what's next? JAMA. 2018;320:757-8.
Kredo T, Bernhardsson S, Machingaidze S, Young T, Louw Q, Ochodo E, et al. Guide to clinical practice guidelines: the current state of play. Int J Qual Health Care. 2016;28:122-8.
Institute of Medicine Committee on Standards for Developing Trustworthy Clinical Practice. In: Graham R, Mancher M, Miller Wolman D, Greenfield S, Steinberg E, editors. Clinical practice guidelines we can trust. Washington, DC: National Academies Press; 2011. [cited 2022 January 4]. Aavilable from: https://www.ncbi.nlm.nih.gov/books/NBK209539/
Turner T, Misso M, Harris C, Green S. Development of evidence-based clinical practice guidelines (CPGs): comparing approaches. Implement Sci. 2008;3:45.
American Academy of Neurology. Clinical practice guideline process manual. 2011th ed. St Paul, MN: American Academy of Neurology; 2011.
WHO handbook for guideline development. 2nd ed. Geneva, Switzerland: World Health Organization; 2014.
Sauro KM, Wiebe S, Dunkley C, Janszky J, Kumlien E, Moshe S, et al. The current state of epilepsy guidelines: a systematic review. Epilepsia. 2016;57:13-23.
De Boeck K, Castellani C, Elborn JS, Board E. Medical consensus, guidelines, and position papers: a policy for the ECFS. J Cyst Fibros. 2014;13:495-8.
Guyatt G. Users' guide to the medical literature: a manual for evidence-based clinical practice. 3rd ed. New York, NY: McGraw Hill; 2015.
Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane handbook for systematic reviews of interventions. 2nd ed. Chichester, UK: John Wiley & Sons; 2019.
Ingravallo F, Dietrich CF, Gilja OH, Piscaglia F. Guidelines, clinical practice recommendations, position papers and consensus statements: definition, preparation, role and application. Ultraschall Med. 2014;35:395-9.
Kea B, Sun BC. Consensus development for healthcare professionals. Intern Emerg Med. 2015;10:373-83.
Murphy MK, Black NA, Lamping DL, McKee CM, Sanderson CF, Askham J, et al. Consensus development methods, and their use in clinical guideline development. Health Technol Assess. 1998;2:i-iv, 1-88.
Fountain NB, Van Ness PC, Swain-Eng R, Tonn S, Bever CT, Neurology AA, et al. Quality improvement in neurology: AAN epilepsy quality measures. Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology. Neurology. 2011;76:94-9.
Institute of Medicine (US) committee on the public health dimensions of the epilepsies, England MJ, Liverman CT, Schultz AM, Strawbridge LM, editorsEpilepsy across the spectrum: promoting health and understanding. Washington, DC: National Academies Press; 2012.
Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet. 1993;342:1317-22.
Lugtenberg M, Burgers JS, Westert GP. Effects of evidence-based clinical practice guidelines on quality of care: a systematic review. Qual Saf Health Care. 2009;18:385-92.
French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, et al. Efficacy and tolerability of the new antiepileptic drugs. I: Treatment of new-onset epilepsy: report of the TTA and QSS subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia. 2004;45:401-9.
French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, et al. Efficacy and tolerability of the new antiepileptic drugs. II: Treatment of refractory epilepsy: report of the TTA and QSS subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia. 2004;45:410-23.
Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. Can Med Assoc J. 2010;182:E839-42.
ADAPTE Collaboration. The ADAPTE process: resource toolkit for guideline adaptation. Berlin, Germany: Guidelines International Network; 2009.
Ketola E, Kaila M, Honkanen M. Guidelines in context of evidence. Qual Saf Health Care. 2007;16:308-12.
Aleksovska K, Kobulashvili T, Costa J, Zimmermann G, Ritchie K, Reinhard C, et al. European Academy of Neurology guidance for developing and reporting clinical practice guidelines on rare neurological diseases. Eur J Neurol. 2022;29:1571-86.
Sauro KM, Wiebe S, Perucca E, French J, Dunkley C, de Marinis A, et al. Developing clinical practice guidelines for epilepsy: a report from the ILAE Epilepsy Guidelines Working Group. Epilepsia. 2015;56:1859-69.
Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
Sterne JAC, Savovic J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.
Sterne JA, Hernan MA, Reeves BC, Savovic J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.
Higgins JP, Savovic J, Page MJ, Elbers RG, Sterne JA. Cochrane handbook for systematic reviews of interventions version 6.3. London, UK: Cochrane; 2022. [cited 2022 June 6]. Available from: . https://training.cochrane.org/handbook
Sterne JA, Hernan MA, McAleenan A, Reeves BC, Higgins JP. Assessing the risk of bias in a non-randomized study. Cochrane handbook for systematic reviews of interventions version 63 (updated February 2022). London, UK: Cochrane; 2022. [cited 2022 June 6]. Available from: . https://training.cochrane.org/handbook
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924-6.
Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. 2013. [cited 2022 June 6]. Available from: https://gdt.gradepro.org/app/handbook/handbook.html
Davis J, Roberts R, Davidson DLW, Norman A, Ogston S, Grimshaw JM, et al. Implementation strategies for a Scottish national epilepsy guideline in primary care: results of the Tayside Implementation of Guidelines in Epilepsy Randomized (TIGER) trial. Epilepsia. 2004;45:28-34.
Grol R. Successes and failures in the implementation of evidence-based guidelines for clinical practice. Med Care. 2001;39:II46-54.
Schuster MA, McGlynn EA, Brook RH. How good is the quality of health care in the United States? Milbank Q. 1998;76:517-63, 509.
Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients' care. Lancet. 2003;362:1225-30.
Sauro KM, Jette N, Quan H, Holroyd-Leduc J, DeCoster C, Wiebe S. Improving knowledge translation of clinical practice guidelines for epilepsy. Epilepsy Behav. 2019;92:265-8.
Farquhar CM, Kofa EW, Slutsky JR. Clinicians' attitudes to clinical practice guidelines: a systematic review. Med J Aust. 2002;177:502-6.
Greco PJ, Eisenberg JM. Changing physicians practices. N Engl J Med. 1993;329:1271-4.
Oxman AD, Thomson MA, Davis DA, Haynes RB. No magic bullets-a systematic review of 102 trials of interventions to improve professional practice. Can Med Assoc J. 1995;153:1423-31.
Wiebe S. Still an elusive target: guiding practice for epilepsy surgery. Neurology. 2010;75:678-9.
Williams B, Skinner J, Dowell J, Roberts R, Crombie I, Davis J. General practitioners' reasons for the failure of a randomized controlled trial (the TIGER trial) to implement epilepsy guidelines in primary care. Epilepsia. 2007;48:1275-82.
Fischer F, Lange K, Klose K, Greiner W, Kraemer A. Barriers and strategies in guideline implementation-a scoping review. Healthcare (Basel). 2016;4:36.
Wilmshurst JM, Cross JH, Newton C, Kakooza AM, Wammanda RD, Mallewa M, et al. Children with epilepsy in Africa: recommendations from the International Child Neurology Association/African Child Neurology Association Workshop. J Child Neurol. 2013;28:633-44.
Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6:42.
Choi H, Sell RL, Lenert L, Muennig P, Goodman RR, Gilliam FG, et al. Epilepsy surgery for pharmacoresistant temporal lobe epilepsy: a decision analysis. JAMA. 2008;300:2497-505.
Jehi L, Yardi R, Chagin K, Tassi L, Russo GL, Worrell G, et al. Development and validation of nomograms to provide individualised predictions of seizure outcomes after epilepsy surgery: a retrospective analysis. Lancet Neurol. 2015;14:283-90.
Jette N, Quan H, Tellez-Zenteno JF, Macrodimitris S, Hader WJ, Sherman EM, et al. Development of an online tool to determine appropriateness for an epilepsy surgery evaluation. Neurology. 2012;79:1084-93.
Flanagan ME, Ramanujam R, Doebbeling BN. The effect of provider- and workflow-focused strategies for guideline implementation on provider acceptance. Implement Sci. 2009;4:71.
Davis D, O'Brien MAT, Freemantle N, Wolf FM, Mazmanian P, Taylor-Vaisey A. Impact of formal continuing medical education-do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes? JAMA. 1999;282:867-74.
British Paediatric Neurology Association. Short courses. [cited 2022 Apr 15]. Available from: https://courses.bpna.org.uk
Thomson O'Brien MA, Oxman AD, Haynes RB, Davis DA, Freemantle N, Harvey EL. Local opinion leaders: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2000;(2):CD000125. https://doi.org/10.1002/14651858
Hunt DL, Haynes RB, Hanna SE, Smith K. Effects of computer-based clinical decision support systems on physician performance and patient outcomes: a systematic review. JAMA. 1998;280:1339-46.
Sakurai R, Ohe K. Effects of computerized guideline-oriented clinical decision support system on antithrombotic therapy in patients with atrial fibrillation: a systematic review and meta-analysis. Stud Health Technol Inform. 2019;264:768-72.
Grimshaw J, Eccles M, Thomas R, MacLennan G, Ramsay C, Fraser C, et al. Toward evidence-based quality improvement. Evidence (and its limitations) of the effectiveness of guideline dissemination and implementation strategies 1966-1998. J Gen Intern Med. 2006;21(Suppl 2):S14-20.
Kirkpatrick M, Dunkley C, Ferrie C, Flower D, Waldron B, Whitehouse WP, et al. Guidelines, training, audit, and quality standards in children's epilepsy services: closing the loop. Seizure. 2014;23:864-8.